Genetic and clinical contributions to cerebral palsy: a multi-variable analysis

Area of Science:

• Genetics
• Perinatal Medicine
• Epidemiology

Background:

• Cerebral palsy (CP) is a complex neurological disorder with multifactorial causes.
• Genetic predisposition and environmental factors, such as maternal infection, are implicated in CP development.
• Single nucleotide polymorphisms (SNPs) are potential genetic markers for CP risk.

Purpose of the Study:

• To investigate the association between specific SNPs and cerebral palsy risk.
• To analyze SNP-SNP and SNP-maternal infection interactions in the context of CP.
• To adjust for clinical confounders in a multi-variable analysis of CP risk factors.

Main Methods:

• A case-control study involving 587 children with CP and 1154 controls.
• Genotyping of 39 candidate SNPs in mothers and children.
• Data linkage with perinatal records and maternal questionnaires for infection history.

Main Results:

• Maternal and fetal carriage of the inducible nitric oxide synthase (iNOS) SNP rs1137933 showed a significant negative association with CP in infants born before 32 weeks gestation.
• Adjusted odds ratios for iNOS SNP rs1137933 were 0.55 (maternal) and 0.57 (fetal).
• No statistically significant interactions were detected between SNPs or between SNPs and maternal infection after multiple testing correction.

Conclusions:

• Maternal and child iNOS SNPs are associated with a decreased risk of cerebral palsy in very preterm infants.
• The study found no evidence supporting SNP-SNP or SNP-maternal infection interactions as significant modulators of CP risk.
• These findings contribute to understanding the genetic underpinnings of CP in preterm neonates.